International Journal of Dentistry and Oral Science (IJDOS)  /  Oral Microbiology and Dental Infection"  /  IJDOS-2377-8075-S4-02-0017

Prevalence Of Homogenous And Non Homogenous Leukoplakia In A Private Dental Hospital


Md Sohaib Shahzan1, Manjari Chaudhary2*, Madhulaxmi Marimuthu3

1 Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
2 Senior Lecturer, Department of Oral Medicine, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
3 Professor, Department of Oral Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University,Chennai, India.


*Corresponding Author

Dr Manjari Chaudhary,
Senior Lecturer, Department of Oral Medicine, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
Tel: + 91 7044455554
E-mail: manjaric.sdc@saveetha.com

Received: August 16, 2020; Accepted: August 27, 2020; Published: August 30, 2020

Citation:Md Sohaib Shahzan, Manjari Chaudhary, Madhulaxmi Marimuthu. Prevalence Of Homogenous And Non Homogenous Leukoplakia In A Private Dental Hospital. Int J Dentistry Oral Sci. 2020;S4:02:0016:88-92. doi: dx.doi.org/10.19070/2377-8075-SI02-040017

Copyright: Manjari Chaudhary© 2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.



Abstract

Leukoplakia is thickened,white patches inside the mouth, mostly non-cancerous premalignant lesions. it'sclassified in two main types: Homogenous and Non homogenous types. Homogenous leukoplakia may be auniform white area, flat appearance and texture although there could also besuperficial irregularities. Non homogenous leukoplakia has non uniform appearance,surface texture is irregular-flat, nodular or exophytic. The aim is to find the prevalence of homogenous and non homogenous leukoplakia in patients visiting Saveetha dental college and hospitals. It is a retrospective study. We reviewed patient records and analysed the infoof 86000 patients between June 2019 and March 2020.The results were analysed using chi-square test. The statistical software used is SPSS by IBM. In total 96 cases were confirmed.Prevalence was found to be 0.23% and was more common in males than in females. Leukoplakia was more prevalent within the age groupbetween 40- 80 years. Homogenous type is more prevalent than non homogenous type.Within the bounds of study it is concluded that leukoplakia features a prevalence of 0.23% and it most ordinarily affects men older than 40 years. Homogenous type is more prevalent than non homogenous type.



1.Keywords
2.Introduction
3.Materials and Method
4.Results And Discussion
5.Conclusion
6.References

Keywords

Leukoplakia; Homogenous; Non Homogenous; Prevalence; Pre Malignant Lesion.


Introduction

Leukoplakia is thickened,white patches inside the mouth ,mostly non cancerous premalignant lesion [4]. The patches cannot be scraped off. The World Health Organization (WHO) defined leukoplakia as “A predominantly white patch or plaque that can't be characterized clinically or pathologically as the other disorder.

Leukoplakia may be a descriptive term that ought to only be applied after other possible causes are ruled out [23, 32]. Tissue biopsy generally shows increased keratin build up with or without abnormal cells, but isn't diagnostic [6, 33]. In recent years there has been development of varied lesions, developmental anomalies and various malignancies [7]. Other conditions which will appear similar include yeast infections, lichen planus, and keratosis due to repeated minor [28, 33]. The lesions from a yeast infection can typically be rubbed off while those of leukoplakia cannot [23].

Classification

Oral Leukoplakia is classified in two main types: homogeneous type which appears as a flat white lesion and non-.homogeneous type [34].

Homogenous leukoplakia

Homogenous leukoplakia (also termed "thick leukoplakia") is typically well defined white patch of uniform, flat appearance and texture, although there could also be superficial irregularities [4, 20]. Homogenous leukoplakia is typically slightly elevated compared to surrounding mucosa, and sometimes features a fissured, wrinkled or corrugated surface texture, with the feel generally consistent throughout the entire lesion [4, 27]. This term has no implications on the dimensions of the lesion, which can be localized or extensive [4, 35]. When homogenous leukoplakia is palpated, it's going to feel leathery, dry, or like cracked mud.

Non-homogenous leukoplakia

Non-homogenous leukoplakia may be a lesion of non-uniform appearance. the colour could also be predominantly white or a mixed white and red. The surface texture is irregular compared to homogenous leukoplakia, and should be flat (papular), nodular [26, 16]. Non-homogeneous leukoplakias have a greater risk of cancerous changes than homogeneous leukoplakias [16].

Etiology

The exact underlying explanation for leukoplakia is essentially unknown, but it's likely multifactorial, with the most factor being the utilization of tobacco [23, 31, 24, 35]. Other risk factors for formation inside the mouth include smoking, excessive alcohol, and use of betel nuts [33, 5]. It's far more common among smokers than among non-smokers [34].

Signs and symptoms

Most cases of leukoplakia cause no symptoms, but infrequently there could also be discomfort or pain [4, 25]. The precise appearance of the lesion is variable. Leukoplakia could also be white, whitish yellow or green [17]. The dimensions can range from a little area to much larger lesions [2]. The foremost common sites affected are the buccal mucosa, the labial mucosa and therefore the alveolar mucosa, although any mucosal surface within the mouth could also be involved [4, 8, 6, 25]. The clinical appearance, including the surface texture and color, could also be homogenous or nonhomogeneous. Some signs are generally related to a better risk of cancerous changes.

Treatment planning

At the primary , the ceasing of the risk activities like smoking is suggested. Further, the histopathological evaluation is required . The degree of dysplasia will guide the selection of the treatment. The surgical procedure can use conventional surgery or laser ablation, electrocauterization, or cryosurgery [17, 29]. The medical treatment uses local and systemic chemopreventive agents like vitamin A , systemic beta carotene, lycopene , ketorolac , local bleomycin [17, 21]. Another possible choice is an attitude of "wait and see" to keep oral leukoplakia under clinical and histological surveillance with frequent visits and biopsies without other treatment. This follow-up can observe an early malignant transformation and subsequent specific treatment [17, 7, 22, 6, 18]. This study throws in some light that focuses to find out the prevalence of leukoplakia among south Indian population – a primary step in understanding the disorder.Thus the aim of the study is to analyse the prevalence of homogenous and non homogenous leukoplakia in patients visiting Saveetha Dental College.


Materials and Methods

The study was administered in an institutional setting with the advantage being an outsized data availability and therefore the disadvantages being assessment of patients belonging to an identical geographic location. The ethical approval was provided by the Institutional ethical committee. The study included all the patients visiting Saveetha Dental College and hospitals (SDC) from June 2019-February 2020. Patients with clinically diagnosed leukoplakia were filtered and demographics of the info were studied. The collected data was subjected to photographic-cross verification.

Inclusion criteria was patients with clinically diagnosed leukoplakia. Cases which didn't fall into this inclusion criteria were excluded from the study.The study was supported non probability convenience sampling. To minimise the sampling bias, all the case sheets of patients with clinically diagnosed leukoplakia were reviewed and included.

We reviewed patient records and analysed the info of 86000 patients between June 2019 and March 2020.The data collected was statistically analysed using SPSS version 20.0. Descriptive statistics and chi square tests were performed and graphs were plotted to reach final results.


Results And Discussion

The prevalence of leukoplakia varies round the world, but generally speaking it's not an uncommon condition [14]. Reported prevalence estimates range from less than 1% to more than 5% within the general population [30]. Leukoplakia is therefore the foremost common premalignant lesion that happens within the mouth [11]. In areas of the world where smokeless tobacco use is common, there's a higher prevalence [13]. within the year 1992, Gupta et al. found a good range of leukoplakia prevalence in various populations. In India, leukoplakia was found in 0.2% and 4.9% of the population [12]. Bánóczy 1983 found that the adult population prevalence varied between 0.6% and 3.6% [1]. Martorell-Calatayud et al. found the prevalence of Oral leukoplakia ranges from 0.4% to 0.7% of the population [19]. [11] Feller and Lemmer estimated the prevalence of Oral leukoplakia ranged from 0.5% to 3.46%, %. Brouns et al. found the prevalence of Oral Leukoplakia is approximately 2% [3]. The present study shows the prevalence rate of 0.23%.There are multiple various prevalence rate across the world as there are conditions which can have certain changes with the changing geographic location and race/ethnicity. This might have been due to the definitive diagnostic criteria getting used within the other studies.

Bánóczy revealed the prevalence of leukoplakia within the age-group of 51-60 years [1]. Espinoza 2003 reported the higher prevalence after 50 years aged [10]. Liu et al. conducted study on 218 patients and he found that peak incidence was the fifth decade of life [15]. All the results being almost like the results of this study.

Bánóczy revealed the prevalence of leukoplakia more in males than in females [1]. Espinoza 2003 reported the higher prevalence present in men [10]. Downer and Petti found leukoplakia to be significantly more prevalent in males [9]. All the results being almost like the results of this study.

Brouns et al. 2013 during a study found that homogeneous leukoplakia was more prevalent than non-homogeneous leukoplakia [3]. The result's almost like the results of this study. Since homogenous leukoplakia are multifactorial the higher incidence of it occurring becomes difficult to be explained. It might be due to variation within the availability of tobacco products, consumption of tobacco with or without calcium hydroxide, duration and frequency of tobacco products combined with alcohol usage within the Indian population [1].

This study wasn't free from all limitations-it had its share of limitations. The criteria (inclusion and exclusion) were termed accordingly and no standardisation criteria was used. The results obtained were highly subjective. No information regarding the other systemic factors and factors not included within the exclusion and exclusion criteria was considered within the research. due to this,few patients who might suffer from leukoplakia could have been excluded.



Figure 1. Bar graph depicting the prevalence of leukoplakia among male and female.X-axis shows the status of leukoplakia and Y-axis shows the number of patients in both genders. Blue bar represents male patients and green bar represents female patients. It shows that leukoplakia is more prevalent in males (95.79%).



Figure 2. Bar graph depicting the Prevalence of leukoplakia among age groups.X-axis shows the status of leukoplakia and Y- axis shows the number of patients in the age groups. Blue bar are patients of age group 0-40 years and green bar are patients of age group 41-80 years. It shows that leukoplakia is more prevalent in patients of age group 41-80 years (74.74%).



Figure 3. Bar chart depicting the prevalence of leukoplakia in patients visiting private dental hospital in 1 year. X axis represents the presence of leukoplakia in patients and Y axis represents the number of patients visiting private dental hospital in one year's time. White bar represents leukoplakia present in patients and the brown bar represents leukoplakia absent in patients. It shows that the prevalence of leukoplakia is 0.23%.



Figure 4. Bar graph depicting the association between gender and prevalence of homogenous and non homogenous leukoplakia in male and female .X-axis shows the types of leukoplakia - homogeneous and nonhomogeneous and Y-axis shows the number of patients in both genders. Blue bar represents male patients and green bar represents female patients. It shows that both homogenous(73.68%) and nonhomogeneous (22.11%) leukoplakia are more prevalent in males. Association between homogenous and non homogenous leukoplakia among males and females and chi square test was done with p value 0.219, where p>0.05 ( statistically insignificant).



Figure 5. Bar chart depicting the association between age and prevalence among homogenous and non homogenous leukoplakia in male and female.X-axis shows the types of leukoplakia - homogeneous and nonhomogeneous and Y- axis shows the number of patients in the age groups. Blue bars are patients of age group 0-40 and green bars are patients of age group 41-80. It shows that both homogenous(54.74%) and non homogenous leukoplakia(20%) are more prevalent in patients of age group 41-80 years. Association between age and prevalence among homogenous and non-homogenous leukoplakia in males and females was done using chi square test, p value 0.318, where p>0.05 (statistically insignificant).


Conclusion

Within the limits of present study, it can be concluded that leukoplakia most commonly affects men older than 40 years and has a prevalence of 0.23%. Homogenous type is more common than non-homogenous type of leukoplakia. Further studies should be done with a large sample size and should focus on other factors such as medication intake, nutritional status as a next step.The patient should be made aware of this condition which will help in early diagnosis thus we can improve the quality of life of patients and create a better society.


References

  1. Bánóczy J. Oral leukoplakia and other white lesions of the oral mucosa related to dermatological disorders. J Cutan Pathol. 1983 Aug;10(4):238-56. Pubmed PMID: 6350389.
  2. Brennan PA. Soames’ and Southam's Oral Pathology (2018, ). Edited by: Robinson M Hunter K Pemberton M Sloan P ed. Published by Oxford University Press, UK.
  3. Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18(1):e19-26. Pubmed PMID: 23085711.
  4. Greenberg VJ. Burket's oral medicineDiagnosis and Treatment.
  5. Chaitanya NC, Muthukrishnan A, Krishnaprasad CMS, Sanjuprasanna G, Pillay P, Mounika B. An Insight and Update on the Analgesic Properties of Vitamin C. J Pharm Bioallied Sci. 2018 Jul-Sep;10(3):119-125. Pubmed PMID: 30237682.
  6. Chaitanya NC, Muthukrishnan A, Babu DBG, Kumari CS, Lakshmi MA, Palat G, et al. Role of Vitamin E and Vitamin A in Oral Mucositis Induced by Cancer Chemo/Radiotherapy- A Meta-analysis. J Clin Diagn Res. 2017 May;11(5):ZE06-ZE09. Pubmed PMID: 28658926.
  7. Choudhury P, Panigrahi RG, Maragathavalli, Panigrahi A, Patra PC. Vanishing roots: first case report of idiopathic multiple cervico-apical external root resorption. J Clin Diagn Res. 2015 Mar;9(3):ZD17-9. Pubmed PMID: 25954713.
  8. Dharman S, Muthukrishnan A. Oral mucous membrane pemphigoid - Two case reports with varied clinical presentation. J Indian Soc Periodontol. 2016 Nov-Dec;20(6):630-634. Pubmed PMID: 29238145.
  9. Downer MC, Petti S. Leukoplakia prevalence estimate lower than expected. Evid Based Dent. 2005;6(1):12; author reply 13-4. Pubmed PMID: 15789044.
  10. Espinoza I, Rojas R, Aranda W, Gamonal J. Prevalence of oral mucosal lesions in elderly people in Santiago, Chile. J Oral Pathol Med. 2003 Nov;32(10):571-5. Pubmed PMID: 14632931.
  11. Feller L, Lemmer J. Oral Leukoplakia as It Relates to HPV Infection: A Review. Int J Dent. 2012;2012:540561. Pubmed PMID: 22505902.
  12. Gupta PC, Mehta FS, Pindborg JJ, Bhonsle RB, Murti PR, Daftary DK, et al. Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med. 1992 Nov;21(10):433-9. Pubmed PMID: 1460581.
  13. Hassona Y, Scully C, Almangush A, Baqain Z, Sawair F. Oral potentially malignant disorders among dental patients: a pilot study in Jordan. Asian Pac J Cancer Prev. 2014;15(23):10427-31. Pubmed PMID: 25556487.
  14. JamesWD, BergerTG, ElstonDM. Andrews’ Diseases of the Skin: Clinical Dermatology. Saunders Elsevier.2006.
  15. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010 Dec 16;10:685. Pubmed PMID: 21159209.
  16. Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;7(7):CD001829. Pubmed PMID: 27471845.
  17. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008 Feb;37(2):63-9. Pubmed PMID: 18197849.
  18. . Maheswari TNU, Venugopal A, Sureshbabu NM, Ramani P. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review. Ci Ji Yi Xue Za Zhi. 2018 Apr-Jun;30(2):55-60. Pubmed PMID: 29875583.
  19. Martorell-Calatayud A, Botella-Estrada R, Bagán-Sebastián JV, Sanmartín- Jiménez O, Guillén-Barona C. La leucoplasia oral: definición de parámetros clínicos, histopatológicos y moleculares y actitud terapéutica [Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach]. Actas Dermosifiliogr. 2009 Oct;100(8):669-84. Spanish. Pubmed PMID: 19775545.
  20. Misra SR, Shankar YU, Rastogi V, Maragathavalli G. Metastatic hepatocellular carcinoma in the maxilla and mandible, an extremely rare presentation. Contemp Clin Dent. 2015 Mar;6(Suppl 1):S117-21. Pubmed PMID: 25821363.
  21. Muthukrishnan A, Bijai Kumar L. Actinic cheilosis: early intervention prevents malignant transformation. BMJ Case Rep. 2017 Mar 20;2017:bcr2016218654. Pubmed PMID: 28320702.
  22. Muthukrishnan A, Bijai Kumar L, Ramalingam G. Medication-related osteonecrosis of the jaw: a dentist's nightmare. BMJ Case Rep. 2016 Apr 6;2016:bcr2016214626. Pubmed PMID: 27053542.
  23. NevilleBW. Oral and Maxillofacial Pathology. Saunders/Elsevier.2009.
  24. Patil SR, Maragathavalli G, Araki K, Al-Zoubi IA, Sghaireen MG, Gudipaneni RK, et al. Three-rooted mandibular first molars in a Saudi Arabian population: A CBCT study. Pesquisa brasileira em odontopediatria e clinica integrada. 2018 Aug 27;18(1):4133.
  25. Rohini S, Kumar VJ. Incidence of dental caries and pericoronitis associated with impacted mandibular third molar–A radiographic study. Research Journal of Pharmacy and Technology. 2017 Apr 1;10(4):1081.
  26. Scully C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Elsevier Health Sciences.2013.
  27. Steele JC, Clark HJ, Hong CH, Jurge S, Muthukrishnan A, Kerr AR, et al. World Workshop on Oral Medicine VI: an international validation study of clinical competencies for advanced training in oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Aug;120(2):143-51.e7. pubmed PMID: 25861956.
  28. Subashri A, Maheshwari TU. Knowledge and attitude of oral hygiene practice among dental students. Research Journal of Pharmacy and Technology. 2016 Nov 1;9(11):1840.
  29. Subha M, Arvind M. Role of magnetic resonance imaging in evaluation of trigeminal neuralgia with its anatomical correlation. Biomedical and Pharmacology Journal. 2019 Mar 25;12(1):289-96.
  30. Tanaka T, Tanaka M, Tanaka T. Oral carcinogenesis and oral cancer chemoprevention: a review. Patholog Res Int. 2011;2011:431246. Pubmed PMID: 21660266.
  31. Underner M, Perriot J, Peiffer G. Le snus [Smokeless tobacco]. Presse Med. 2012 Jan;41(1):3-9. French. Pubmed PMID: 21840161.
  32. Venugopal A, Uma Maheswari TN. Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review. J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):474-479. Pubmed PMID: 27721614.
  33. Villa A, Woo SB. Leukoplakia-A Diagnostic and Management Algorithm. J Oral Maxillofac Surg. 2017 Apr;75(4):723-734. Pubmed PMID: 27865803.
  34. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80. Pubmed PMID: 17944749.
  35. Muthukrishnan A, Warnakulasuriya S. Oral health consequences of smokeless tobacco use. Indian J Med Res. 2018 Jul;148(1):35-40. Pubmed PMID: 30264752.

         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn